References
- Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol. 2020;18(7):392–407. doi:10.1038/s41579-020-0331-1
- Tortoli E, Fedrizzi T, Meehan CJ, et al. The new phylogeny of the genus Mycobacterium: the old and the news. Infect Genet Evol. 2017;56:19–25. doi:10.1016/j.meegid.2017.10.013
- van der Werf MJ, Kodmon C, Katalinic-Jankovic V, et al. Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis. 2014:14. doi:10.1186/1471-2334-14-14
- Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620. doi:10.1146/annurev.immunol.20.081501.125851
- Daley CL. Nontuberculous mycobacterial disease in transplant recipients: early diagnosis and treatment. Curr Opin Organ Transplant. 2009;14(6):619–624. doi:10.1097/MOT.0b013e3283327cd6
- Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36(1):91–99. doi:10.1016/j.ccm.2014.11.002
- Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15(8):968–980. doi:10.1016/S1473-3099(15)00089-4
- Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN. The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases. PLoS Neglect Trop Dis. 2019;13(2):e0007083. doi:10.1371/journal.pntd.0007083
- Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in US medicare beneficiaries. Am J Resp Crit Care. 2012;185(8):881–886. doi:10.1164/rccm.201111-2016OC
- Gordin FM, Masur H. Current Approaches to Tuberculosis in the United States. J Am Med Assoc. 2012;308(3):283–289. doi:10.1001/jama.2012.7505
- Tortoli E, Rogasi PG, Fantoni E, Beltrami C, De Francisci A, Mariottini A. Infection due to a novel mycobacterium, mimicking multidrug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect. 2010;16(8):1130–1134. doi:10.1111/j.1469-0691.2009.03063.x
- Raju RM, Raju SM, Zhao YL, Rubin EJ. Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease. Emerg Infect Dis. 2016;22(3):365–369. doi:10.3201/eid2203.151643
- Piersimoni C, Scarparo C. Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis. 2008;8(5):323–334. doi:10.1016/S1473-3099(08)70100-2
- Shahraki AH, Heidarieh P, Bostanabad SZ, et al. “Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria. Eur J Intern Med. 2015;26(4):279–284. doi:10.1016/j.ejim.2015.03.001
- Huo FM, Ma YF, Liu RM, et al. Interpretation of discordant rifampicin susceptibility test results obtained using GeneXpert vs phenotypic drug susceptibility testing. Open Forum Infect Dis. 2020;7(8):ofaa279.
- Liu G, Chen ST, Yu X, et al. Bacteriological and virulence study of a Mycobacterium chimaera isolate from a patient in China. Antonie Van Leeuwenhoek. 2015;107(4):901–909. doi:10.1007/s10482-015-0382-x
- Forbes BA, Hall GS, Miller MB, et al. Practice guidelines for clinical microbiology laboratories: mycobacteria. Clin Microbiol Rev. 2018;31(2). doi:10.1128/CMR.00038-17.
- McGrath EE, Anderson PB. Increased prevalence of non-tuberculous mycobacteria infection. Lancet. 2007;370(9581):28. doi:10.1016/S0140-6736(07)61044-7
- Yu X, Liu PNA, Liu G, et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect. 2016;73(6):558–567. doi:10.1016/j.jinf.2016.08.020
- Pang Y, Tan YJ, Chen J, et al. Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study. Eur Respir J. 2017;49(3):1601429. doi:10.1183/13993003.01429-2016
- Zhou L, Xu D, Liu HC, Wan KL, Wang RB, Yang ZC. Trends in the prevalence and antibiotic resistance of non-tuberculous mycobacteria in Mainland China, 2000–2019: systematic review and meta-analysis. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00295
- Wang XB, Li H, Jiang GL, et al. Prevalence and drug resistance of nontuberculous mycobacteria, Northern China, 2008–2011. Emerg Infect Dis. 2014;20(7):1252–1253. doi:10.3201/eid2007.131801
- Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535. doi:10.1183/13993003.00535-2020
- Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Resp Crit Care. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
- Chikamatsu K, Aono A, Yamada H, et al. Comparative evaluation of three immunochromatographic identification tests for culture confirmation of Mycobacterium tuberculosis complex. BMC Infect Dis. 2014;14:1–7.
- Yu MC, Chen HY, Wu MH, et al. Evaluation of the rapid MGIT TBc identification test for culture confirmation of Mycobacterium tuberculosis complex strain detection. J Clin Microbiol. 2011;49(3):802–807. doi:10.1128/JCM.02243-10